We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

50% of Trial Subjects Who Took a Placebo Reported Suffering an Adverse Event

News   Dec 12, 2018 | Original story from BMC

 
50% of Trial Subjects Who Took a Placebo Reported Suffering an Adverse Event

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

New Immune Cell on the Block During Viral Lung Infections

News

Scientists have identified a novel group of immune cells in the lungs that are associated with the control of inflammation during viral infections, like influenza or possibly coronavirus. This discovery may help to advance the development of therapeutics to treat inflammation-related lung conditions such as bronchitis, influenza and potentially even COVID-19.

READ MORE

COVID-19: Stopgap Measure Proposed for Respiratory Distress

News

Researchers at MIT and the University of Colorado at Denver have proposed a stopgap measure that they believe could help Covid-19 patients who are in acute respiratory distress. By repurposing a drug that is now used to treat blood clots, they believe they could help people in cases where a ventilator is not helping, or if a ventilator is not available.

READ MORE

"Blink-on-a-chip" Could Test Eye-drop Drugs

News

A new approach could lead to “cornea-on-a-chip” devices that more accurately test the effects of drugs on the human eye.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE